Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28911 |
Tafetinib
SIM-010603,SIM010603,SIM 010603 |
Tyrosine Kinases | Tyrosine Kinase/Adaptors |
Tafetinib (SIM-010603) 是一种新型有效且可口服的酪氨酸激酶抑制剂,具有抗血管生成和抗肿瘤活性。 | |||
T71575 |
Dioxifedrine
|
||
Dioxifedrine is a beta-2 -adrenergic agonist with bronchodilator activity. | |||
T71576 |
SIM010603
|
||
SIM010603 is a structurally novel, oral, multi-targeted receptor tyrosine kinase inhibitor. SIM010603 inhibited stem cell factor receptor (Kit), vascular endothelial growth factor receptor-2 (VEGFR-2), platelet-derived growth factor receptor-β (PDGFR-β), glial cell line-derived neurotrophic factor receptor (Rearranged during Transfection; RET), and Fms-like tyrosine kinase-3 (FLT3) with IC(50) values between 5.0 and 68.1 nmol/l. SIM010603 inhibited the phosphorylation of PDGFR-β and VEGFR-2. Mor... |